HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francesco Di Virgilio Selected Research

Pyrimidine Nucleotides

1/2020Ectonucleotidases in Acute and Chronic Inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francesco Di Virgilio Research Topics

Disease

44Neoplasms (Cancer)
01/2022 - 02/2005
35Inflammation (Inflammations)
03/2022 - 03/2003
8Infections
01/2020 - 12/2003
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 01/2012
4Pneumonia (Pneumonitis)
07/2018 - 08/2007
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2017 - 01/2002
3Melanoma (Melanoma, Malignant)
01/2022 - 01/2020
3Lung Diseases (Lung Disease)
05/2017 - 08/2008
3Chronic Obstructive Pulmonary Disease (COPD)
03/2011 - 05/2010
2Disease Progression
01/2022 - 01/2017
2Carcinogenesis
01/2022 - 02/2009
2Glioblastoma (Glioblastoma Multiforme)
01/2022 - 08/2019
2Neoplasm Metastasis (Metastasis)
12/2021 - 11/2021
2Neuroinflammatory Diseases
05/2021 - 12/2017
2Malignant Mesothelioma
01/2021 - 08/2016
2Leukemia
01/2020 - 01/2017
2Neuroblastoma
01/2020 - 01/2006
2Pulmonary Fibrosis (Fibrosing Alveolitis)
05/2017 - 01/2017
2Fibrosis (Cirrhosis)
05/2017 - 01/2017
2Lung Injury
01/2017 - 07/2010
2Tuberculosis (Tuberculoses)
12/2013 - 11/2006
2Necrosis
01/2013 - 12/2012
2Pain (Aches)
01/2013 - 07/2012
2Emphysema
03/2011 - 07/2010
2Bacterial Infections (Bacterial Infection)
11/2006 - 01/2006
1Insulin Resistance
03/2022
1Intervertebral Disc Degeneration
01/2022
1Blindness (Hysterical Blindness)
07/2021
1Diabetic Retinopathy (Retinopathy, Diabetic)
07/2021
1Cicatrix (Scar)
01/2021
1Skin Diseases (Skin Disease)
01/2021
1Bone Diseases (Bone Disease)
01/2021
1Rupture
01/2021
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2021
1Suppuration
01/2021
1Hyperuricemia
01/2021
1Gout
01/2021
1Hidradenitis Suppurativa
01/2021
1COVID-19
11/2020
1Cytokine Release Syndrome
11/2020
1Osteoporosis
01/2020

Drug/Important Bio-Agent (IBA)

47Adenosine Triphosphate (ATP)IBA
01/2022 - 04/2003
30Purinergic P2X7 ReceptorsIBA
03/2022 - 01/2002
13CytokinesIBA
03/2022 - 04/2003
13Purinergic Receptors (Receptors, Purine)IBA
01/2022 - 11/2006
12NucleotidesIBA
01/2021 - 03/2003
5Adenosine (Adenocard)FDA LinkGeneric
01/2022 - 11/2012
5InflammasomesIBA
01/2022 - 07/2010
5Proteins (Proteins, Gene)FDA Link
07/2018 - 07/2003
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 06/2012
4Uridine Triphosphate (UTP)IBA
01/2020 - 07/2003
3Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2019
3Protein Isoforms (Isoforms)IBA
01/2022 - 01/2014
3purineIBA
01/2021 - 01/2018
3Pharmaceutical PreparationsIBA
01/2019 - 02/2002
3LipopolysaccharidesIBA
07/2018 - 11/2006
3Purinergic P2 Receptors (ADP Receptor)IBA
02/2015 - 03/2011
2InterleukinsIBA
01/2022 - 01/2020
2(N-(1-(((cyanoimino)(5-quinolinylamino) methyl) amino)- 2,2- dimethylpropyl)- 2- (3,4- dimethoxyphenyl)acetamide)IBA
12/2021 - 01/2019
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2021 - 01/2019
2Bevacizumab (Avastin)FDA Link
07/2021 - 06/2012
2AZ10606120IBA
01/2021 - 08/2016
2denatonium (denatonium benzoate)IBA
01/2021 - 01/2020
2NucleotidasesIBA
11/2020 - 01/2020
2Daunorubicin (Cerubidine)FDA LinkGeneric
10/2020 - 01/2017
2EnzymesIBA
01/2020 - 01/2011
2Adenosine Diphosphate (ADP)IBA
01/2020 - 02/2002
2Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
06/2019 - 07/2010
2Bleomycin (Blenoxane)FDA LinkGeneric
05/2017 - 01/2017
2AntigensIBA
01/2017 - 08/2007
2LuciferasesIBA
02/2015 - 07/2008
2Apyrase (ATP Diphosphatase)IBA
12/2013 - 08/2007
2SmokeIBA
03/2011 - 07/2010
2EndotoxinsIBA
11/2006 - 10/2004
1Insulin (Novolin)FDA Link
03/2022
15- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA
01/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022
1Interferon-gamma (Interferon, gamma)IBA
01/2022
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2022
1Interleukin-17 (Interleukin 17)IBA
01/2022
1Interleukin-12 (IL 12)IBA
01/2022
1Transforming Growth Factor beta (TGF-beta)IBA
01/2022
1Viral AntigensIBA
12/2021
1Methylnitronitrosoguanidine (MNNG)IBA
12/2021
1Biomarkers (Surrogate Marker)IBA
11/2021
1MicroRNAs (MicroRNA)IBA
11/2021
1Ranibizumab (Lucentis)FDA Link
07/2021
1Monoclonal AntibodiesIBA
07/2021
1Hormones (Hormone)IBA
07/2021
1Biological FactorsIBA
05/2021
1N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA
01/2021
1Ion Channels (Ion Channel)IBA
01/2021
1ectoATPaseIBA
11/2020
1A-factor (Streptomyces)IBA
01/2020
1triphosphoric acid (triphosphate)IBA
01/2020
13-hydroxy-5-estrane-17-carbonitrile (ACN)IBA
01/2020
1Tyrosine (L-Tyrosine)FDA Link
01/2020

Therapy/Procedure

19Therapeutics
01/2022 - 10/2004
2Drug Therapy (Chemotherapy)
01/2017 - 11/2016
1Caloric Restriction
01/2022